GRIN2B Mutations in West Syndrome and Intellectual Disability with Focal Epilepsy

Lemke JR, Hendrickx R, Geider K, Laube B, Schwake M, Harvey RJ, James VM, Pepler A, Steiner I, Hoertnagel K, Neidhardt J, et al. (2014)
Annals of Neurology 75(1): 147-154.

Journal Article | Published | English

No fulltext has been uploaded

; ; ; ; ; ; ; ; ; ; ;
Objective: To identify novel epilepsy genes using a panel approach and describe the functional consequences of mutations. Methods: Using a panel approach, we screened 357 patients comprising a vast spectrum of epileptic disorders for defects in genes known to contribute to epilepsy and/or intellectual disability (ID). After detection of mutations in a novel epilepsy gene, we investigated functional effects in Xenopus laevis oocytes and screened a follow-up cohort. Results: We revealed de novo mutations in GRIN2B encoding the NR2B subunit of the N-methyl-D-aspartate (NMDA) receptor in 2 individuals with West syndrome and severe developmental delay as well as 1 individual with ID and focal epilepsy. The patient with ID and focal epilepsy had a missense mutation in the extracellular glutamate-binding domain (p.Arg540His), whereas both West syndrome patients carried missense mutations within the NR2B ion channel-forming re-entrant loop (p.Asn615Ile, p.Val618Gly). Subsequent screening of 47 patients with unexplained infantile spasms did not reveal additional de novo mutations, but detected a carrier of a novel inherited GRIN2B splice site variant in close proximity (c.2011-5_2011-4delTC). Mutations p.Asn615Ile and p.Val618Gly cause a significantly reduced Mg2+ block and higher Ca2+ permeability, leading to a dramatically increased Ca2+ influx, whereas p.Arg540His caused less severe disturbance of channel function, corresponding to the milder patient phenotype. Interpretation: We identified GRIN2B gain-of-function mutations as a cause of West syndrome with severe developmental delay as well as of ID with childhood onset focal epilepsy. Severely disturbed channel function corresponded to severe clinical phenotypes, underlining the important role of facilitated NMDA receptor signaling in epileptogenesis.
Publishing Year

Cite this

Lemke JR, Hendrickx R, Geider K, et al. GRIN2B Mutations in West Syndrome and Intellectual Disability with Focal Epilepsy. Annals of Neurology. 2014;75(1):147-154.
Lemke, J. R., Hendrickx, R., Geider, K., Laube, B., Schwake, M., Harvey, R. J., James, V. M., et al. (2014). GRIN2B Mutations in West Syndrome and Intellectual Disability with Focal Epilepsy. Annals of Neurology, 75(1), 147-154.
Lemke, J. R., Hendrickx, R., Geider, K., Laube, B., Schwake, M., Harvey, R. J., James, V. M., Pepler, A., Steiner, I., Hoertnagel, K., et al. (2014). GRIN2B Mutations in West Syndrome and Intellectual Disability with Focal Epilepsy. Annals of Neurology 75, 147-154.
Lemke, J.R., et al., 2014. GRIN2B Mutations in West Syndrome and Intellectual Disability with Focal Epilepsy. Annals of Neurology, 75(1), p 147-154.
J.R. Lemke, et al., “GRIN2B Mutations in West Syndrome and Intellectual Disability with Focal Epilepsy”, Annals of Neurology, vol. 75, 2014, pp. 147-154.
Lemke, J.R., Hendrickx, R., Geider, K., Laube, B., Schwake, M., Harvey, R.J., James, V.M., Pepler, A., Steiner, I., Hoertnagel, K., Neidhardt, J., Ruf, S., Wolff, M., Bartholdi, D., Caraballo, R., Platzer, K., Suls, A., De Jonghe, P., Biskup, S., Weckhuysen, S.: GRIN2B Mutations in West Syndrome and Intellectual Disability with Focal Epilepsy. Annals of Neurology. 75, 147-154 (2014).
Lemke, Johannes R., Hendrickx, Rik, Geider, Kirsten, Laube, Bodo, Schwake, Michael, Harvey, Robert J., James, Victoria M., Pepler, Alex, Steiner, Isabelle, Hoertnagel, Konstanze, Neidhardt, John, Ruf, Susanne, Wolff, Markus, Bartholdi, Deborah, Caraballo, Roberto, Platzer, Konrad, Suls, Arvid, De Jonghe, Peter, Biskup, Saskia, and Weckhuysen, Sarah. “GRIN2B Mutations in West Syndrome and Intellectual Disability with Focal Epilepsy”. Annals of Neurology 75.1 (2014): 147-154.
This data publication is cited in the following publications:
This publication cites the following data publications:

18 Citations in Europe PMC

Data provided by Europe PubMed Central.

Delineating the GRIN1 phenotypic spectrum: A distinct genetic NMDA receptor encephalopathy.
Lemke JR, Geider K, Helbig KL, Heyne HO, Schutz H, Hentschel J, Courage C, Depienne C, Nava C, Heron D, Moller RS, Hjalgrim H, Lal D, Neubauer BA, Nurnberg P, Thiele H, Kurlemann G, Arnold GL, Bhambhani V, Bartholdi D, Pedurupillay CR, Misceo D, Frengen E, Stromme P, Dlugos DJ, Doherty ES, Bijlsma EK, Ruivenkamp CA, Hoffer MJ, Goldstein A, Rajan DS, Narayanan V, Ramsey K, Belnap N, Schrauwen I, Richholt R, Koeleman BP, Sa J, Mendonca C, de Kovel CG, Weckhuysen S, Hardies K, De Jonghe P, De Meirleir L, Milh M, Badens C, Lebrun M, Busa T, Francannet C, Piton A, Riesch E, Biskup S, Vogt H, Dorn T, Helbig I, Michaud JL, Laube B, Syrbe S., Neurology 86(23), 2016
PMID: 27164704
Evaluation of Presumably Disease Causing SCN1A Variants in a Cohort of Common Epilepsy Syndromes.
Lal D, Reinthaler EM, Dejanovic B, May P, Thiele H, Lehesjoki AE, Schwarz G, Riesch E, Ikram MA, van Duijn CM, Uitterlinden AG, Hofman A, Steinbock H, Gruber-Sedlmayr U, Neophytou B, Zara F, Hahn A; Genetic Commission of the Italian League against Epilepsy; EuroEPINOMICS CoGIE Consortium, Gormley P, Becker F, Weber YG, Cilio MR, Kunz WS, Krause R, Zimprich F, Lemke JR, Nurnberg P, Sander T, Lerche H, Neubauer BA, Bianchi A, Bianchi A, La Neve A, Striano P, Minetti C, Giuseppe C, Lerche H, Palotie A, Lehesjoki AE, Ruppert AK, Suls A, Siren A, Neophytou B, Koeleman B, Lal D, Haberlandt E, Reinthaler EM, Zara F, Becker F, Zimprich F, Ronen GM, Caglayan H, Hjalgrim H, Muhle H, Steinbock H, Schulz H, Lerche H, Thiele H, Helbig I, Altmuller J, Geldner J, Schubert J, Jabbari K, Everett K, Feucht M, Balestri M, Nothnagel M, Striano P, May P, Nurnberg P, Moller RS, Nabbout R, Krause R, Balling R, Baulac S, Sander T, Gruber-Sedlmayr U, Kunz W, Weber YG., PLoS ONE 11(3), 2016
PMID: 26990884
Genes with de novo mutations are shared by four neuropsychiatric disorders discovered from NPdenovo database.
Li J, Cai T, Jiang Y, Chen H, He X, Chen C, Li X, Shao Q, Ran X, Li Z, Xia K, Liu C, Sun ZS, Wu J., Mol. Psychiatry 21(2), 2016
PMID: 25849321
Clinical Genetic Testing in Epilepsy.
Mefford HC., Epilepsy Curr 15(4), 2015
PMID: 26316867
Advancing epilepsy genetics in the genomic era.
Myers CT, Mefford HC., Genome Med 7(), 2015
PMID: 26302787
Epilepsy genetics: the ongoing revolution.
Lesca G, Depienne C., Rev. Neurol. (Paris) 171(6-7), 2015
PMID: 26003806
Ionotropic GABA and Glutamate Receptor Mutations and Human Neurologic Diseases.
Yuan H, Low CM, Moody OA, Jenkins A, Traynelis SF., Mol. Pharmacol. 88(1), 2015
PMID: 25904555
Recessive loss-of-function mutations in AP4S1 cause mild fever-sensitive seizures, developmental delay and spastic paraplegia through loss of AP-4 complex assembly.
Hardies K, May P, Djemie T, Tarta-Arsene O, Deconinck T, Craiu D; AR working group of the EuroEPINOMICS RES Consortium, Helbig I, Suls A, Balling R, Weckhuysen S, De Jonghe P, Hirst J, Afawi Z, Barisic N, Baulac S, Caglayan H, Depienne C, De Kovel CG, Dimova P, Guerrero-Lopez R, Guerrini R, Hjalgrim H, Hoffman-Zacharska D, Jahn J, Klein KM, Koeleman BP, Leguern E, Lehesjoki AE, Lemke J, Lerche H, Marini C, Muhle H, Rosenow F, Serratosa JM, Moller RS, Stephani U, Striano P, Talvik T, Von Spiczak S, Weber Y, Zara F., Hum. Mol. Genet. 24(8), 2015
PMID: 25552650
NMDA receptor subunit mutations in neurodevelopmental disorders.
Burnashev N, Szepetowski P., Curr Opin Pharmacol 20(), 2015
PMID: 25498981
Expanding the spectrum of Grik2 mutations: intellectual disability, behavioural disorder, epilepsy and dystonia.
Cordoba M, Rodriguez S, Gonzalez Moron D, Medina N, Kauffman MA., Clin. Genet. 87(3), 2015
PMID: 25039795
De novo mutations in moderate or severe intellectual disability.
Hamdan FF, Srour M, Capo-Chichi JM, Daoud H, Nassif C, Patry L, Massicotte C, Ambalavanan A, Spiegelman D, Diallo O, Henrion E, Dionne-Laporte A, Fougerat A, Pshezhetsky AV, Venkateswaran S, Rouleau GA, Michaud JL., PLoS Genet. 10(10), 2014
PMID: 25356899
De novo mutations in synaptic transmission genes including DNM1 cause epileptic encephalopathies.
EuroEPINOMICS-RES Consortium; Epilepsy Phenome/Genome Project; Epi4K Consortium, Appenzeller S, Balling R, Barisic N, Baulac S, Caglayan H, Craiu D, De Jonghe P, Depienne C, Dimova P, Djemie T, Gormley P, Guerrini R, Helbig I, Hjalgrim H, Hoffman-Zacharska D, Jahn J, Klein KM, Koeleman B, Komarek V, Krause R, Kuhlenbaumer G, Leguern E, Lehesjoki AE, Lemke JR, Lerche H, Linnankivi T, Marini C, May P, Moller RS, Muhle H, Pal D, Palotie A, Pendziwiat M, Robbiano A, Roelens F, Rosenow F, Selmer K, Serratosa JM, Sisodiya S, Stephani U, Sterbova K, Striano P, Suls A, Talvik T, von Spiczak S, Weber Y, Weckhuysen S, Zara F, Abou-Khalil B, Alldredge BK, Andermann E, Andermann F, Amron D, Bautista JF, Berkovic SF, Bluvstein J, Boro A, Cascino G, Consalvo D, Crumrine P, Devinsky O, Dlugos D, Epstein MP, Fiol M, Fountain NB, French J, Friedman D, Geller EB, Glauser T, Glynn S, Haas K, Haut SR, Hayward J, Helmers SL, Joshi S, Kanner A, Kirsch HE, Knowlton RC, Kossoff EH, Kuperman R, Kuzniecky R, Lowenstein DH, McGuire SM, Motika PV, Novotny EJ, Ottman R, Paolicchi JM, Parent J, Park K, Poduri A, Sadleir L, Scheffer IE, Shellhaas RA, Sherr E, Shih JJ, Singh R, Sirven J, Smith MC, Sullivan J, Thio LL, Venkat A, Vining EP, Von Allmen GK, Weisenberg JL, Widdess-Walsh P, Winawer MR, Allen AS, Berkovic SF, Cossette P, Delanty N, Dlugos D, Eichler EE, Epstein MP, Glauser T, Goldstein DB, Han Y, Heinzen EL, Johnson MR, Kuzniecky R, Lowenstein DH, Marson AG, Mefford HC, Nieh SE, O'Brien TJ, Ottman R, Petrou S, Petrovski S, Poduri A, Ruzzo EK, Scheffer IE, Sherr E., Am. J. Hum. Genet. 95(4), 2014
PMID: 25262651
Harnessing gene expression networks to prioritize candidate epileptic encephalopathy genes.
Oliver KL, Lukic V, Thorne NP, Berkovic SF, Scheffer IE, Bahlo M., PLoS ONE 9(7), 2014
PMID: 25014031
Three rare diseases in one Sib pair: RAI1, PCK1, GRIN2B mutations associated with Smith-Magenis Syndrome, cytosolic PEPCK deficiency and NMDA receptor glutamate insensitivity.
Adams DR, Yuan H, Holyoak T, Arajs KH, Hakimi P, Markello TC, Wolfe LA, Vilboux T, Burton BK, Fajardo KF, Grahame G, Holloman C, Sincan M, Smith AC, Wells GA, Huang Y, Vega H, Snyder JP, Golas GA, Tifft CJ, Boerkoel CF, Hanson RW, Traynelis SF, Kerr DS, Gahl WA., Mol. Genet. Metab. 113(3), 2014
PMID: 24863970
Glutamate receptor mutations in psychiatric and neurodevelopmental disorders.
Soto D, Altafaj X, Sindreu C, Bayes A., Commun Integr Biol 7(1), 2014
PMID: 24605182

30 References

Data provided by Europe PubMed Central.

Evidence for a tetrameric structure of recombinant NMDA receptors.
Laube B, Kuhse J, Betz H., J. Neurosci. 18(8), 1998
PMID: 9526012
Molecular basis of NMDA receptor functional diversity.
Paoletti P., Eur. J. Neurosci. 33(8), 2011
PMID: 21395862
Range of genetic mutations associated with severe non-syndromic sporadic intellectual disability: an exome sequencing study.
Rauch A, Wieczorek D, Graf E, Wieland T, Endele S, Schwarzmayr T, Albrecht B, Bartholdi D, Beygo J, Di Donato N, Dufke A, Cremer K, Hempel M, Horn D, Hoyer J, Joset P, Ropke A, Moog U, Riess A, Thiel CT, Tzschach A, Wiesener A, Wohlleber E, Zweier C, Ekici AB, Zink AM, Rump A, Meisinger C, Grallert H, Sticht H, Schenck A, Engels H, Rappold G, Schrock E, Wieacker P, Riess O, Meitinger T, Reis A, Strom TM., Lancet 380(9854), 2012
PMID: 23020937
The NMDA receptor complex as a therapeutic target in epilepsy: a review.
Ghasemi M, Schachter SC., Epilepsy Behav 22(4), 2011
PMID: 22056342


0 Marked Publications

Open Data PUB

Web of Science

View record in Web of Science®


PMID: 24272827
PubMed | Europe PMC

Search this title in

Google Scholar